Infection and anti-tumor necrosis factor-alpha therapy

Israel Medical Association Journal

Volumn 5, Issue 11, 2003, Pages 814-816

  Zandman Goddard, Gisele ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Etanercept; Histoplasmosis; Infection; Infliximab; Listeria; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ISONIAZID; LIVE VACCINE; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIBODY PRODUCTION; ASPERGILLOSIS; ATYPICAL MYCOBACTERIOSIS; AUTOIMMUNE DISEASE; BACTERIAL ARTHRITIS; BACTERIAL INFECTION; CANDIDIASIS; CARDIOVASCULAR DISEASE; CELLULITIS; CLINICAL TRIAL; COCCIDIOIDOMYCOSIS; COUGHING; CROHN DISEASE; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EXPOSURE; DRUG FATALITY; DRUG FEVER; DRUG SAFETY; DYSPNEA; EDITORIAL; HISTOPLASMOSIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOTHERAPY; INCIDENCE; INFECTION; INTERSTITIAL PNEUMONIA; LEGIONNAIRE DISEASE; LISTERIA; LISTERIOSIS; LOW DRUG DOSE; LYMPHOMA; MALAISE; MENINGITIS; MUCORMYCOSIS; MYCOSIS; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PROTEIN FUNCTION; RESPIRATORY TRACT INFECTION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SALMONELLOSIS; SEPSIS; SIDE EFFECT; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; TUBERCULOSIS; VIRUS INFECTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; CROHN DISEASE; HISTOPLASMOSIS; HUMANS; LISTERIA INFECTIONS; OPPORTUNISTIC INFECTIONS; RHEUMATIC DISEASES; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0344876553     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Cunnane G, Doran M, Bresnihan B. Infections and biological therapy in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:345-63.
2. Bresnihan B, Cunnane G. Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 2003;29:185-202.
3. Dinarello CA. Anti-cytokine therapeutics and infections. Vaccine 2003;21(Suppl 2):S24-34.
4. Lipsky PE, Van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594-602.
5. Remicade - Post-surveillance Update Report, 2002.
6. Tweezer-Zaks N, Shiloach E, Spivak A, Rapoport, M, Novis B, Langevitz P. Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha. IMAJ 2003;5:829-30.
7. Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 2003;48:319-24.
8. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
9. Salmon D; GTI and AFSSAPS. Groupe Tuberculose et infliximab. Agence Francaise de Securite Sanitaire de Produits de Sante. Recommendations about the prevention and management of tuberculosis in patients taking infliximab. Joint Bone Spine 2002; 69:170-2.
10. Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002;46:2565-70.
11. Tai TL, O'Rourke KP, McWeeney M, Burke CM, Sheehan K, Barray M. Pneumocystis carinii pneumonia following a second infusion of infliximab. Rheumatology (Oxford) 2002;41:951-2.
12. Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001;344:1099-100.
13. Helbling D, Breitbach TH, Krause M. Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol 2002;14:1393-5.
14. Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-a therapy. Rheumatology 2003;42:617-21.